Analyst Consensus
- Current Price
- 113.87 $
- Target (Low)
- 100.00 $
- Target (Mean)
- 129.74 $
- Target (High)
- 150.00 $
- Recommendation
- Buy
- Number of Analysts
- 27
Recommendation Distribution
Recommendation Distribution| Strong Buy | 4 |
|---|
| Buy | 15 |
|---|
| Hold | 10 |
|---|
| Sell | 0 |
|---|
| Strong Sell | 0 |
|---|
Key Ratios
- Net Profit Margin
- 13.6%
- Operating Margin
- 38.6%
- Gross Margin
- 76.7%
- Return on Equity (ROE)
- 18.9%
- Return on Assets (ROA)
- 12.6%
- Revenue Growth
- 4.9%
- Debt/Equity
- 106.94
- Current Ratio
- 1.30
- Beta
- 0.22
Recent Rating Changes
Recent Rating Changes| Date | Firm | Change |
|---|
| May 1, 2026 | Wells Fargo | Overweight → Overweight |
| Apr 13, 2026 | UBS | Buy → Buy |
| Apr 6, 2026 | JP Morgan | Overweight → Overweight |
| Mar 30, 2026 | RBC Capital | Outperform → Outperform |
| Mar 20, 2026 | Citigroup | Neutral → Neutral |
| Mar 12, 2026 | Wells Fargo | Overweight → Overweight |